{
  "DOI": "10.1038/s41431-019-0480-8",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-019-0480-8",
  "alternative-id": [
    "480"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "15 March 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "3 July 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "17 July 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "29 July 2019"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Petrović",
      "given": "Jelena",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Pešić",
      "given": "Vesna",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-1140-6204",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Lauschke",
      "given": "Volker M.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        7,
        29
      ]
    ],
    "date-time": "2019-07-29T14:03:35Z",
    "timestamp": 1564409015000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        20
      ]
    ],
    "date-time": "2023-05-20T21:00:19Z",
    "timestamp": 1684616419000
  },
  "funder": [
    {
      "DOI": "10.13039/501100004359",
      "award": [
        "2016-01154"
      ],
      "doi-asserted-by": "publisher",
      "name": "Vetenskapsrådet"
    },
    {
      "DOI": "10.13039/100010661",
      "award": [
        "668353"
      ],
      "doi-asserted-by": "publisher",
      "name": "EC | Horizon 2020 Framework Programme"
    },
    {
      "name": "Lennart Philipson Foundation Harald and Greta Jeansson Foundation"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        5,
        1
      ]
    ],
    "date-time": "2024-05-01T18:09:22Z",
    "timestamp": 1714586962076
  },
  "is-referenced-by-count": 70,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2019,
        7,
        29
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2020,
          1
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            7,
            29
          ]
        ],
        "date-time": "2019-07-29T00:00:00Z",
        "timestamp": 1564358400000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            7,
            29
          ]
        ],
        "date-time": "2019-07-29T00:00:00Z",
        "timestamp": 1564358400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/s41431-019-0480-8.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-019-0480-8",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-019-0480-8.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "88-94",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2019,
        7,
        29
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        7,
        29
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2020,
        1
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1046/j.0306-5251.2001.01407.x",
      "author": "P Impicciatore",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "journal-title": "Br J Clin Pharmacol",
      "key": "480_CR1",
      "unstructured": "Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol. 2001;52:77–83.",
      "volume": "52",
      "year": "2001"
    },
    {
      "DOI": "10.1136/bmj.329.7456.15",
      "author": "M Pirmohamed",
      "doi-asserted-by": "publisher",
      "first-page": "15",
      "journal-title": "Brit Med J",
      "key": "480_CR2",
      "unstructured": "Pirmohamed M, James S, Meakin S, Green S, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Brit Med J. 2004;329:15–9.",
      "volume": "329",
      "year": "2004"
    },
    {
      "DOI": "10.7326/0003-4819-147-11-200712040-00006",
      "author": "DS Budnitz",
      "doi-asserted-by": "publisher",
      "first-page": "755",
      "journal-title": "Ann Intern Med",
      "key": "480_CR3",
      "unstructured": "Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med. 2007;147:755–65.",
      "volume": "147",
      "year": "2007"
    },
    {
      "DOI": "10.3390/ijms17101714",
      "author": "Volker Lauschke",
      "doi-asserted-by": "publisher",
      "first-page": "1714",
      "issue": "10",
      "journal-title": "International Journal of Molecular Sciences",
      "key": "480_CR4",
      "unstructured": "Lauschke V M, Ingelman-Sundberg M. The importance of patient-specific factors for hepatic drug response and toxicity. Int J Mol Sci. 2016;17:1–27.",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ejps.2019.01.024",
      "author": "VM Lauschke",
      "doi-asserted-by": "publisher",
      "first-page": "65",
      "journal-title": "Eur J Pharm Sci",
      "key": "480_CR5",
      "unstructured": "Lauschke VM, Ingelman-Sundberg M. Prediction of drug response and adverse drug reactions: from twin studies to next generation sequencing. Eur J Pharm Sci. 2019;130:65–77.",
      "volume": "130",
      "year": "2019"
    },
    {
      "DOI": "10.1097/FPC.0000000000000172",
      "author": "K Fujikura",
      "doi-asserted-by": "publisher",
      "first-page": "584",
      "journal-title": "Pharm Genom",
      "key": "480_CR6",
      "unstructured": "Fujikura K, Ingelman-Sundberg M, Lauschke VM. Genetic variation in the human cytochrome P450 supergene family. Pharm Genom. 2015;25:584–94.",
      "volume": "25",
      "year": "2015"
    },
    {
      "DOI": "10.1126/science.286.5439.487",
      "author": "WE Evans",
      "doi-asserted-by": "publisher",
      "first-page": "487",
      "journal-title": "Science",
      "key": "480_CR7",
      "unstructured": "Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science. 1999;286:487–91.",
      "volume": "286",
      "year": "1999"
    },
    {
      "DOI": "10.1016/S0021-9258(17)40694-6",
      "author": "SM de Morais",
      "doi-asserted-by": "crossref",
      "first-page": "15419",
      "journal-title": "J Biol Chem",
      "key": "480_CR8",
      "unstructured": "de Morais SM, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem. 1994;269:15419–22.",
      "volume": "269",
      "year": "1994"
    },
    {
      "DOI": "10.1016/j.clpt.2005.10.002",
      "author": "SC Sim",
      "doi-asserted-by": "publisher",
      "first-page": "103",
      "journal-title": "Clin Pharmacol Ther",
      "key": "480_CR9",
      "unstructured": "Sim SC, Risinger C, Dahl M-L, Aklillu E, Christensen M, Bertilsson L, et al. A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants. Clin Pharmacol Ther. 2006;79:103–13.",
      "volume": "79",
      "year": "2006"
    },
    {
      "DOI": "10.1002/cpt.690",
      "author": "Y Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "688",
      "journal-title": "Clin Pharmacol Ther",
      "key": "480_CR10",
      "unstructured": "Zhou Y, Ingelman-Sundberg M, Lauschke VM. Worldwide distribution of cytochrome P450 alleles: a meta-analysis of population-scale sequencing projects. Clin Pharmacol Ther. 2017;102:688–700.",
      "volume": "102",
      "year": "2017"
    },
    {
      "author": "I Fricke-Galindo",
      "first-page": "113",
      "journal-title": "Pharm J",
      "key": "480_CR11",
      "unstructured": "Fricke-Galindo I, Céspedes-Garro C, Rodrigues-Soares F, Naranjo ME, Delgado A, de Andres F, et al. Interethnic variation of CYP2C19 alleles, ‘predicted’ phenotypes and ‘measured’ metabolic phenotypes across world populations. Pharm J. 2016;16:113–23.",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1038/gim.2016.80",
      "author": "A Gaedigk",
      "doi-asserted-by": "publisher",
      "first-page": "69",
      "journal-title": "Genet Med",
      "key": "480_CR12",
      "unstructured": "Gaedigk A, Sangkuhl K, Whirl-Carrillo M, Klein T, Leeder JS. Prediction of CYP2D6 phenotype from genotype across world populations. Genet Med. 2017;19:69–76.",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nature19057",
      "author": "M Lek",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "journal-title": "Nature",
      "key": "480_CR13",
      "unstructured": "Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–91.",
      "volume": "536",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nature15393",
      "author": "The 1000 Genomes Project Consortium.",
      "doi-asserted-by": "publisher",
      "first-page": "68",
      "journal-title": "Nature",
      "key": "480_CR14",
      "unstructured": "The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature. 2015;526:68–74.",
      "volume": "526",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ejhg.2017.130",
      "author": "A Ameur",
      "doi-asserted-by": "publisher",
      "first-page": "1253",
      "journal-title": "Eur J Hum Genet",
      "key": "480_CR15",
      "unstructured": "Ameur A, Dahlberg J, Olason P, Vezzi F, Karlsson R, Martin M, et al. SweGen: a whole-genome data resource of genetic variability in a cross-section of the Swedish population. Eur J Hum Genet. 2017;25:1253–60.",
      "volume": "25",
      "year": "2017"
    },
    {
      "author": "S Reisberg",
      "first-page": "4",
      "journal-title": "Genet Med",
      "key": "480_CR16",
      "unstructured": "Reisberg S, Krebs K, Lepamets M, Kals M, Mägi R, Metsalu K, et al. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions. Genet Med. 2018;20:4.",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1371/journal.pone.0162866",
      "author": "C Mizzi",
      "doi-asserted-by": "publisher",
      "first-page": "e0162866",
      "journal-title": "PLoS ONE",
      "key": "480_CR17",
      "unstructured": "Mizzi C, Dalabira E, Kumuthini J, Dzimiri N, Balogh I, Basak N, et al. A European spectrum of pharmacogenomic biomarkers: implications for clinical pharmacogenomics. PLoS ONE. 2016;11:e0162866.",
      "volume": "11",
      "year": "2016"
    },
    {
      "DOI": "10.1038/clpt.2008.141",
      "author": "SU Yasuda",
      "doi-asserted-by": "publisher",
      "first-page": "417",
      "journal-title": "Clin Pharmacol Ther",
      "key": "480_CR18",
      "unstructured": "Yasuda SU, Zhang L, Huang S-M. The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies. Clin Pharmacol Ther. 2008;84:417–23.",
      "volume": "84",
      "year": "2008"
    },
    {
      "DOI": "10.1111/j.1472-8206.2007.00510.x",
      "author": "K Arvanitidis",
      "doi-asserted-by": "publisher",
      "first-page": "419",
      "journal-title": "Fundam Clin Pharmacol",
      "key": "480_CR19",
      "unstructured": "Arvanitidis K, Ragia G, Iordanidou M, Kyriaki S, Xanthi A, Tavridou A, et al. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population. Fundam Clin Pharmacol. 2007;21:419–26.",
      "volume": "21",
      "year": "2007"
    },
    {
      "author": "E Aklillu",
      "first-page": "441",
      "journal-title": "J Pharm Exp Ther",
      "key": "480_CR20",
      "unstructured": "Aklillu E, Persson I, Bertilsson L, Johansson I, Rodrigues F, Ingelman-Sundberg M. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. J Pharm Exp Ther. 1996;278:441–6.",
      "volume": "278",
      "year": "1996"
    },
    {
      "DOI": "10.1097/00008571-199706000-00003",
      "author": "RA McLellan",
      "doi-asserted-by": "publisher",
      "first-page": "187",
      "journal-title": "Pharmacogenetics",
      "key": "480_CR21",
      "unstructured": "McLellan RA, Oscarson M, Seidegård J, Evans D, Ingelman-Sundberg M. Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians. Pharmacogenetics. 1997;7:187–91.",
      "volume": "7",
      "year": "1997"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201243",
      "author": "S Fuselli",
      "doi-asserted-by": "publisher",
      "first-page": "916",
      "journal-title": "Eur J Hum Genet",
      "key": "480_CR22",
      "unstructured": "Fuselli S, Dupanloup I, Frigato E, Cruciani F, Scozzari R, Moral P, et al. Molecular diversity at the CYP2D6 locus in the Mediterranean region. Eur J Hum Genet. 2004;12:916–24.",
      "volume": "12",
      "year": "2004"
    },
    {
      "author": "M Ingelman-Sundberg",
      "first-page": "6",
      "journal-title": "Pharm J",
      "key": "480_CR23",
      "unstructured": "Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharm J. 2005;5:6–13.",
      "volume": "5",
      "year": "2005"
    },
    {
      "DOI": "10.1007/s11033-013-2569-4",
      "author": "C Sipeky",
      "doi-asserted-by": "publisher",
      "first-page": "4727",
      "journal-title": "Mol Biol Rep",
      "key": "480_CR24",
      "unstructured": "Sipeky C, Weber A, Szabo M, Melegh BI, Janicsek I, Tarlos G, et al. High prevalence of CYP2C19*2 allele in Roma samples: study on Roma and Hungarian population samples with review of the literature. Mol Biol Rep. 2013;40:4727–35.",
      "volume": "40",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ejhg.2015.201",
      "author": "B Martínez-Cruz",
      "doi-asserted-by": "publisher",
      "first-page": "937",
      "journal-title": "Eur J Hum Genet",
      "key": "480_CR25",
      "unstructured": "Martínez-Cruz B, Mendizabal I, Harmant C, de Pablo R, Ioana M, Angelicheva D, et al. Origins, admixture and founder lineages in European Roma. Eur J Hum Genet. 2016;24:937–43.",
      "volume": "24",
      "year": "2016"
    },
    {
      "DOI": "10.1067/mcp.2000.109365",
      "author": "JK Lamba",
      "doi-asserted-by": "publisher",
      "first-page": "328",
      "journal-title": "Clin Pharmacol Ther",
      "key": "480_CR26",
      "unstructured": "Lamba JK, Dhiman RK, Kohli KK. CYP2C19 genetic mutations in North Indians. Clin Pharmacol Ther. 2000;68:328–35.",
      "volume": "68",
      "year": "2000"
    },
    {
      "DOI": "10.1007/s11033-013-2971-y",
      "author": "J Vicente",
      "doi-asserted-by": "publisher",
      "first-page": "1267",
      "journal-title": "Mol Biol Rep",
      "key": "480_CR27",
      "unstructured": "Vicente J, González-Andrade F, Soriano A, Fanlo A, Martínez-Jarreta B, Sinués B. Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study. Mol Biol Rep. 2014;41:1267–72.",
      "volume": "41",
      "year": "2014"
    },
    {
      "DOI": "10.1111/j.1742-7843.2012.00919.x",
      "author": "FI Al-Jenoobi",
      "doi-asserted-by": "publisher",
      "first-page": "50",
      "journal-title": "Basic Clin Pharmacol Toxicol",
      "key": "480_CR28",
      "unstructured": "Al-Jenoobi FI, Alkharfy KM, Alghamdi AM, Bagulb KM, Al-Mohizea AM, Al-Muhsen S, et al. CYP2C19 genetic polymorphism in Saudi Arabians. Basic Clin Pharmacol Toxicol. 2013;112:50–54.",
      "volume": "112",
      "year": "2013"
    },
    {
      "DOI": "10.7150/ijms.6795",
      "author": "LH Saeed",
      "doi-asserted-by": "publisher",
      "first-page": "1497",
      "journal-title": "Int J Med Sci",
      "key": "480_CR29",
      "unstructured": "Saeed LH, Mayet AY. Genotype-phenotype analysis of CYP2C19 in healthy saudi individuals and its potential clinical implication in drug therapy. Int J Med Sci. 2013;10:1497–502.",
      "volume": "10",
      "year": "2013"
    },
    {
      "author": "M Dehbozorgi",
      "first-page": "4195",
      "journal-title": "Mol Med Rep",
      "key": "480_CR30",
      "unstructured": "Dehbozorgi M, Kamalidehghan B, Hosseini I, Dehghanfard Z, Sangtarash MH, Firoozi M, et al. Prevalence of the CYP2C19*2 (681 G\u003eA), *3 (636 G\u003eA) and *17 (‑806 C\u003eT) alleles among an Iranian population of different ethnicities. Mol Med Rep. 2018;17:4195–202.",
      "volume": "17",
      "year": "2018"
    },
    {
      "author": "SA Scott",
      "first-page": "297",
      "journal-title": "Pharm J",
      "key": "480_CR31",
      "unstructured": "Scott SA, Martis S, Peter I, Kasai Y, Kornreich R, Desnick RJ. Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness. Pharm J. 2012;12:297–305.",
      "volume": "12",
      "year": "2012"
    },
    {
      "DOI": "10.1002/cpt.762",
      "author": "PC Bank",
      "doi-asserted-by": "publisher",
      "first-page": "599",
      "journal-title": "Clin Pharmacol Ther",
      "key": "480_CR32",
      "unstructured": "Bank PC, Caudle KE, Swen JJ, Gammal RS, Whirl-Carrillo M, Klein TE, et al. Comparison of the guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group. Clin Pharmacol Ther. 2018;103:599–618.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1176/appi.ajp.2017.17050550",
      "author": "MM Jukić",
      "doi-asserted-by": "publisher",
      "first-page": "463",
      "journal-title": "Am J Psychiatry",
      "key": "480_CR33",
      "unstructured": "Jukić MM, Haslemo T, Molden E, Ingelman-Sundberg M. Impact of CYP2C19 genotype on escitalopram exposure and therapeutic failure: a retrospective study based on 2,087 patients. Am J Psychiatry. 2018;175:463–70.",
      "volume": "175",
      "year": "2018"
    },
    {
      "DOI": "10.3390/jpm8020015",
      "author": "A Gaedigk",
      "doi-asserted-by": "publisher",
      "first-page": "15",
      "journal-title": "J Pers Med",
      "key": "480_CR34",
      "unstructured": "Gaedigk A, Dinh J, Jeong H, Prasad B, Leeder J. Ten years’ experience with the CYP2D6 activity score: a perspective on future investigations to improve clinical predictions for precision therapeutics. J Pers Med. 2018;8:15.",
      "volume": "8",
      "year": "2018"
    },
    {
      "DOI": "10.1038/gim.2016.33",
      "author": "M Kozyra",
      "doi-asserted-by": "publisher",
      "first-page": "20",
      "journal-title": "Genet Med",
      "key": "480_CR35",
      "unstructured": "Kozyra M, Ingelman-Sundberg M, Lauschke VM. Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response. Genet Med. 2017;19:20–9.",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1002/cpt.350",
      "author": "WS Bush",
      "doi-asserted-by": "publisher",
      "first-page": "160",
      "journal-title": "Clin Pharmacol Ther",
      "key": "480_CR36",
      "unstructured": "Bush WS, Crosslin DR, Owusu-Obeng A, Wallace J, Almoguera B, Basford MA, et al. Genetic variation among 82 pharmacogenes: the PGRNseq data from the eMERGE network. Clin Pharmacol Ther. 2016;100:160–9.",
      "volume": "100",
      "year": "2016"
    },
    {
      "DOI": "10.1186/s40246-018-0157-3",
      "author": "M Ingelman-Sundberg",
      "doi-asserted-by": "publisher",
      "journal-title": "Hum Genom",
      "key": "480_CR37",
      "unstructured": "Ingelman-Sundberg M, Mkrtchian S, Zhou Y, Lauschke VM. Integrating rare genetic variants into pharmacogenetic drug response predictions. Hum Genom. 2018;12:26.",
      "volume": "12",
      "year": "2018"
    },
    {
      "DOI": "10.1038/gim.2017.156",
      "author": "M Santos",
      "doi-asserted-by": "publisher",
      "first-page": "622",
      "journal-title": "Genet Med",
      "key": "480_CR38",
      "unstructured": "Santos M, Niemi M, Hiratsuka M, Kumondai M, Ingelman-Sundberg M, Lauschke VM, et al. Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics. Genet Med. 2018;20:622–9.",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.tips.2015.10.006",
      "author": "VM Lauschke",
      "doi-asserted-by": "publisher",
      "first-page": "85",
      "journal-title": "Trends Pharm Sci",
      "key": "480_CR39",
      "unstructured": "Lauschke VM, Ingelman-Sundberg M. Precision medicine and rare genetic variants. Trends Pharm Sci. 2016;37:85–6.",
      "volume": "37",
      "year": "2016"
    },
    {
      "DOI": "10.1002/cpt.976",
      "author": "VM Lauschke",
      "doi-asserted-by": "publisher",
      "first-page": "745",
      "journal-title": "Clin Pharmacol Ther",
      "key": "480_CR40",
      "unstructured": "Lauschke VM, Ingelman-Sundberg M. How to consider rare genetic variants in personalized drug therapy. Clin Pharmacol Ther. 2018;103:745–8.",
      "volume": "103",
      "year": "2018"
    }
  ],
  "reference-count": 40,
  "references-count": 40,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-019-0480-8"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Frequencies of clinically important CYP2C19 and CYP2D6 alleles are graded across Europe"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "28"
}